companydata.dkPHARMCO II ApS: Financial statements 2016
CVR: 25202899
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -20,625 and a net result of DKK 2,271,044 compared with DKK 2,968,899 the year before. Equity amounted to DKK 56,698,908. The solvency ratio was 99.2%.
- Gross Profit
- -20,625 kr.
- Profit/Loss
- 2,271,044 kr.
- Equity
- 56,698,908 kr.
- Total Assets
- 57,137,741 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -21 t. | 2.3 mio. | 56.7 mio. | - |
| 2015 | - | 17.8 mio. | 3 mio. | - | 37 |
| 2014 | - | -21 t. | 1.8 mio. | 52.8 mio. | 34 |
| 2013 | - | -19 t. | 3.6 mio. | 51.1 mio. | - |
| 2012 | - | -19 t. | 3.6 mio. | 47.7 mio. | - |
How creditworthy is PHARMCO II ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
PHARMCO II ApS has published its annual report for 2015. Gross profit came to DKK 17,759,834, and the net result was DKK 2,968,899.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity amounted to DKK 107,079,000.